Lawrence B. Gardner, MD

About Me

Conditions and Treatments

anemia, bleeding tendency, platelet disorders, sickle cell anemia

Credentials

Positions
  • Associate Professor, Department of Medicine
  • Associate Professor, Department of Biochemistry and Molecular Pharmacology
Board Certifications
  • American Board of Internal Medicine (Hematology), 2001
Education and Training
  • Fellowship, Johns Hopkins University, Oncology, 2000
  • Fellowship, Johns Hopkins Hospital, Hematology, 2000
  • Residency, Johns Hopkins Hospital, Internal Medicine, 1994
  • MD from Yale University, 1993

Locations and Appointments

76 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Affinity
  • Affinity Exchange- Essential
  • Agewell
  • Cigna EPO/POS
  • Cigna PPO
  • ElderPlan
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield HealthPlus
  • Empire Blue Cross Blue Shield HealthPlus Essential
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis Child Health
  • Fidelis Essential
  • Fidelis Exchange
  • Fidelis Family Health
  • Fidelis Medicaid
  • Fidelis Medicare
  • GHI CBP
  • HIP Access I
  • HIP Access II
  • HIP Child Health
  • HIP EPO/PPO
  • HIP Essential
  • HIP Family Health
  • HIP HMO
  • HIP Medicaid
  • HIP Medicare
  • HIP POS
  • HealthSmart (WTC)
  • Healthfirst
  • Healthfirst Essential
  • Humana Medicare
  • Independent Care System New York
  • Local 1199 PPO
  • MagnaCare PPO
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Essential
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • MetroPlus Medicare
  • MultiPlan/PHCS PPO
  • NY Medicaid
  • NYS Empire Plan
  • Oscar
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • PHP
  • Railroad Medicare
  • Tricare
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare Core and Charter
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • Village Caremax
  • Visiting Nurse Service (VNS) Medicare
  • WellCare Child Health
  • WellCare Family Health
  • WellCare Medicaid
  • WellCare Medicare
  • Wellcare Exchange
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.
NYU Hematology Associates

240 East 38th Street, 19th Floor
New York, NY 10016

Contact

Phone: 212-731-5650

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

We use a variety of molecular biology, cell biology, and biochemical techniques to determine how cells adapt to cellular stress (e.g. hypoxia and nutrient deprivation).  We are specifically interested in how cancer cells adapt to their microenvironment, with the hope that disrupting these adaptive responses can serve as effective therapies. Over the past several years we have focused on a RNA surveillance mechanism termed nonsense mediated RNA decay (NMD).  We have found that NMD is turned off by a diverse number of cellular stresses.  Accordingly, NMD is inhibited in tumors.  The inhibition of NMD activates several pathways implicated in cancer, and helps cells grow as three dimensional tumors.

Publications

  • Clinical and laboratory characteristics associated with a high optical density anti-platelet factor 4 ELISA test

    Lu, Benjamin Y; Kudlowitz, David; Gardner, Lawrence B
    Journal of blood medicine. 2015 Nov 19. 6: 277-283

  • Cellular adaptation to nutrient deprivation: crosstalk between the mTORC1 and eIF2alpha signaling pathways and implications for autophagy

    Wengrod, Jordan C; Gardner, Lawrence B
    Cell cycle. 2015 . 14 (16): 2571-2577

  • Phosphorylation of eIF2alpha triggered by mTORC1 inhibition and PP6C activation is required for autophagy and is aberrant in PP6C-mutated melanoma

    Wengrod, Jordan; Wang, Ding; Weiss, Sarah; Zhong, Hua; Osman, Iman; Gardner, Lawrence B
    Science signaling. 2015 Mar 10. 8 (367): ra27-ra27 ra27

Read All Publications (32)